Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cronos Group Inc (CRON) vs SpaceX (SPCX) Price & Performance

Cronos Group IncTrade
SpaceXTrade

Price performance (Past 24H)

Key statistics

Cronos Group Inc vs SpaceX — how do they compare? Cronos Group Inc trades at $2.76 (market cap $1.02B), while SpaceX trades at $137.66 (market cap $1.79T). The key difference: SpaceX is far larger — about 1754.9× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, SpaceX nearer its low. Which is the better fit depends on your goals.

CRONSPCX
Market Cap
$1.02B$1.79T
Sector
HealthTechnology
52-Week High
$3.27$202.09
52-Week Low
$1.95$135.00
Enterprise Value
$203.29M$1.81T

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cronos Group Inc

CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.

Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.

SpaceX

SpaceX (SPCX) trades at $139.14, down 4.33% with bearish technical signals despite analyst optimism. The stock shows weak fundamentals with negative profitability (-45% net margin) and extreme valuations (P/S 92.17, EV/EBITDA 957.25). Recent Q1 2026 earnings missed expectations, though inclusion in the Nasdaq-100 provides institutional support. Cash flow remains positive primarily from financing activities.

Long-term growth potential in space economy contrasts with current overvaluation and execution risks. Analyst consensus remains bullish with $239.23 price target, but investors face volatility from high valuations and geopolitical tensions. The stock presents high-risk speculation on future space dominance rather than current fundamentals.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON

About SpaceX

SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.

Read more on SPCX